MBX Biosciences (MBX) Other Non-Current Assets (2023 - 2026)
MBX Biosciences (MBX) reported Other Non-Current Assets of $200000.0 for Q1 2026, up 300.0% on a YoY basis from $50000.0 in Q1 2025, and up 300.0% sequentially from $50000.0 in Q3 2025.
MBX Biosciences (MBX) Other Non-Current Assets (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Other Non-Current Assets data on file, last reported at $200000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 300.0% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $200000.0 (up 300.0% YoY), and the FY2024 full-year result was $50000.0, changed 0.0% from the prior year.
- Other Non-Current Assets rose to $200000.0 in Q1 2026, from $50000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $200000.0 in Q1 2026 to a low of $50000.0 in Q4 2023.
- A 4-year average of $71428.6 and a median of $50000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2024 and jumped 300.0% in 2026, its largest moves.
- Tracing MBX's Other Non-Current Assets over 4 years: stood at $50000.0 in 2023, then changed by 0.0% to $50000.0 in 2024, then changed by 0.0% to $50000.0 in 2025, then jumped by 300.0% to $200000.0 in 2026.
- Business Quant data shows MBX's Other Non-Current Assets at $200000.0 in Q1 2026, $50000.0 in Q3 2025, and $50000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |